The RNA Component of Human Telomerase
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Eukaryotic chromosomes are capped with repetitive telomere sequences that protect the ends from damage and rearrangements. Telomere repeats are synthesized by telomerase, a ribonucleic acid (RNA)-protein complex. Here, the cloning of the RNA component of human telomerase, termed hTR, is described. The template region of hTR encompasses 11 nucleotides (5′-CUAACCCUAAC) complementary to the human telomere sequence (TTAGGG) n . Germline tissues and tumor cell lines expressed more hTR than normal somatic cells and tissues, which have no detectable telomerase activity. Human cell lines that expressed hTR mutated in the template region generated the predicted mutant telomerase activity. HeLa cells transfected with an antisense hTR lost telomeric DNA and began to die after 23 to 26 doublings. Thus, human telomerase is a critical enzyme for the long-term proliferation of immortal tumor cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Key components of telomerase are telomerase reverse transcriptase (TERT) (88) and telomerase RNA (89).”
From The Discovery of Reverse Transcriptase (2016) · cites this paper as [89]
In the citing paper
“expression of antisense RNA complementary to the human telomerase RNA component (hTR) caused decreased proliferation of HeLa cells after 23 to 26 doublings (24).”
From Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death (1999) · cites this paper as [24]
In the citing paper
“The shortening of telomeres occurs with each cell division, ultimately causing cells to reach their Hayflick limit, whereby growth stops after approximately 60 times population doubling [2,3,4,5].”
From Cell Immortality: In Vitro Effective Techniques to Achieve and Investigate Its Applications and Challenges (2024) · cites this paper as [5]
In the citing paper
“When telomeres become too short and cannot function naturally, cellular senescence in the M1 phase (a cellular growth arrest, also called the M1 stage) occurs [5,6,7].”
From Cell Immortality: In Vitro Effective Techniques to Achieve and Investigate Its Applications and Challenges (2024) · cites this paper as [5]
In the citing paper
“In human cells, the enzyme comprises a high molecular weight complex with a template-containing RNA subunit (Feng et al., 1995) and protein components including the catalytic subunit human telomerase reverse transcriptase, hTERT (Harrington et al., 1997;Meyerson et al., 1997;Nakamura et al., 1997).”
From A highly selective telomerase inhibitor limiting human cancer cell proliferation (2001) · cites this paper as Feng et al., 1995
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091
Self-citationTelomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Self-citationTight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943
Identification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400
Self-citationTelomere length predicts replicative capacity of human fibroblasts.
Allsopp, R. C., Vaziri, H., Patterson, C., Goldstein, S., Younglai, E. V., Futcher, A. B., Greider, C. W., & Harley, C. B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10114 · Cited by 2,200
Self-citationCounter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N. G., Greider, C. W., Harley, C. B., & Bacchetti, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05245.x · Cited by 2,096
Self-citationOlovnikov (1973) · doi:10.1016/0022-5193(73)90198-7 · Cited by 1,847
Telomere reduction in human colorectal carcinoma and with ageing
Hastie, N. D., Dempster, M., Dunlop, M. G., Thompson, A. M., Green, D. K., & Allshire, R. C. (1990) · Nature · doi:10.1038/346866a0 · Cited by 1,650
A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis
Greider, C. W., & Blackburn, E. H. (1989) · Nature · doi:10.1038/337331a0 · Cited by 1,643
Self-citation
Research works printed but not linked: 7
- AUTEXIER, C, FUNCTIONAL RECONSTITUTION OF WILD-TYPE AND MUTANT TETRAHYMENA TELOMERASE, GENES & DEVELOPMENT 8: 563 (1994). · DOI
- AVILION A.A. THESIS STATE U NEW Y (1995).
- Broccoli, D., Proceedings of the National Academy of Sciences of the United States of America 92: 9082 (1995).
- CHADENEAU, C, ONCOGENE 11: 841 (1995).
- Hernandez, N., Transcriptional Regulation: 281 (1992).
- Muller, H. J., Collecting Net 13: 181 (1938).
- WATSON, J. D., NATURE-NEW BIOLOGY 239: 197 (1972).
Cited by
Items 501–600 of 1,003
Zhuang, Y., Zhang, M., Chen, B., Duan, R., Min, X., Zhang, Z., Zheng, F., Liang, H., Zhao, Z., Lou, X., et al. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b02699 · Cited by 79
Noureen, N., Wu, S., Lv, Y., Yang, J., Yung, W. K. A., Gelfond, J., Wang, X., Koul, D., Ludlow, A. T., & Zheng, S. (2021) · Nature Communications · doi:10.1038/s41467-020-20474-9 · Cited by 82
Thymidine nucleotide metabolism controls human telomere length
Mannherz, W. P., & Agarwal, S. (2023) · Nature Genetics · doi:10.1038/s41588-023-01339-5 · Cited by 86
“This shortening is counteracted by telomerase, a reverse transcriptase 6 that uses an RNA template 7 , telomerase RNA component ( TERC ), to synthesize new telomeric repeats 8 .”
BackgroundKanzawa, T., Germano, I. M., Kondo, Y., Ito, H., Kyo, S., & Kondo, S. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601193 · Cited by 83
“Three components of human telomerase have been recently identified: the RNA component (hTER) (Feng et al, 1995), the telomerase-associated protein (TEP1) (Harrington et al, 1997; Nakayama et al, 1997), and the telomerase reverse transcriptase (hTERT) (Meyerson et al, 1997; Nakamura et al, 1997).”
BackgroundTelomerase-independent Regulation of ATR by Human Telomerase RNA
Kedde, M., le Sage, C., Duursma, A. M., Zlotorynski, E., van Leeuwen, B., Nijkamp, W., Beijersbergen, R. L., & Agami, R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607676200 · Cited by 86
Bilsland, A. E., Anderson, C. J., Fletcher‐Monaghan, A. J., McGregor, F., Evans, T. R. J., Ganly, I., Knox, R. J., Plumb, J. A., & Keith, W. N. (2003) · Oncogene · doi:10.1038/sj.onc.1206168 · Cited by 85
“The transcriptional start site for the hTR promoter defined here confirms that transcription of NTR from the Ad-hTR-NTR vector initiates 46 bp upstream of the start of the hTR template sequence, at the site that was previously described (Feng et al., 1995).”
Telomerase as a therapeutic target for malignant gliomas
Komata, T., Kanzawa, T., Kondo, Y., & Kondo, S. (2002) · Oncogene · doi:10.1038/sj.onc.1205072 · Cited by 85
“Feng et al. (1995) demonstrated that introduction of a construct expressing an antisense transcript to the ®rst 185 nucleotides of the RNA induced cell death in HeLa cells after 23 ± 26 doublings.”
BackgroundTelomeres and Telomerase: A Simple Picture Becomes Complex
Lundblad, V., & Wright, W. E. (1996) · Cell · doi:10.1016/s0092-8674(00)81358-6 · Cited by 82
Defining the transcriptomic landscape of Candida glabrata by RNA-Seq
Linde, J., Duggan, S., Weber, M., Horn, F., Sieber, P., Hellwig, D., Riege, K., Marz, M., Martin, R., Guthke, R., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1357 · Cited by 75
“In comparison to the CGDB annotation, GORAP failed to identify three ncRNAs that we added manually: the telomerase TLC1 (CAGL0I04700r), which extends telomere ends by a repetitive sequence motif (81), the RNA component of the mitochondrial RNase and RNase P (CaglfM01) (82) and the snRNA H1 (CAGL0L08044r).”
MethodKeppler, B. R., Grady, A. T., & Jarstfer, M. B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511067200 · Cited by 89
Evolution of Cancer Vaccines—Challenges, Achievements, and Future Directions
Tay, B. Q., Wright, Q., Ladwa, R., Perry, C., Leggatt, G., Simpson, F., Wells, J. W., Panizza, B. J., Frazer, I. H., & Cruz, J. L. G. (2021) · Vaccines · doi:10.3390/vaccines9050535 · Cited by 76
“The telomerase enzyme consists of a large ribonucleoprotein complex composed by two subunits, the human telomerase RNA component (hTERC or hTR) and human telomerase reverse transcriptase (hTERT) encoded by the TERT gene [93,94].”
BackgroundAn Enhanced H/ACA RNP Assembly Mechanism for Human Telomerase RNA
Egan, E. D., & Collins, K. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00286-12 · Cited by 76
“This model has the appeal of accounting for a complete lack of a recognizable or required 3= end formation signal downstream of mature hTR at its genomic locus (15, 17, 32).”
BackgroundInfluentialLiu, X., Zhou, Y., Lou, Y., & Zhong, H. (2015) · Gene · doi:10.1016/j.gene.2015.11.009 · Cited by 80
Telomerase as a Cancer Target. Development of New Molecules
Mengual Gomez, D. L., Armando, R. G., Cerrudo, C. S., Ghiringhelli, P. D., & Gomez, D. E. (2016) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026616666160212122425 · Cited by 73
“Feng et al reported that antisense oligonucleotides complementary to sequences within or near the human telomeric template RNA resulted in suppression of telomerase activity while antisense oligonucleotides against targets that were more distant from the telomeric template failed to inhibit the action of the ribonucle…”
BackgroundInduction of Apoptosis by Telomere 3′ Overhang-Specific DNA
Eller, M. S., Puri, N., Hadshiew, I., Venna, S. S., & Gilchrest, B. A. (2002) · Experimental Cell Research · doi:10.1006/excr.2002.5531 · Cited by 78
Phosphorylation of TPP1 regulates cell cycle-dependent telomerase recruitment
Zhang, Y., Chen, L.-Y., Han, X., Xie, W., Kim, H., Yang, D., Liu, D., & Songyang, Z. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217733110 · Cited by 73
Poluch, S., Drian, M.-J., Durand, M., Astier, C., Benyamin, Y., & K�nig, N. (2001) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20010101)63:1<35::aid-jnr5>3.0.co;2-1 · Cited by 52
Telomerase and Cancer Stem Cells
ARMANIOS, M., & GREIDER, C. W. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.030 · Cited by 76
Self-citationA human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT
Cerone, M. A., Autexier, C., Londoño‐Vallejo, A., & Bacchetti, S. (2005) · Oncogene · doi:10.1038/sj.onc.1208934 · Cited by 89
“For telomerase activity specified by hTR-MuA, 5mg of extracts were used in the assay using conditions and primers described for this mutant (Feng et al., 1995).”
MethodInhibition of telomerase activity in human cancer cells by RNA interference.
Kosciolek, B. A., Kalantidis, K., Tabler, M., & Rowley, P. T. (2003) · PubMed · Cited by 89
Structure and function of telomerase
Collins, K. (1996) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(96)80013-5 · Cited by 76
Masutomi, K., & Hahn, W. C. (2003) · Cancer Letters · doi:10.1016/s0304-3835(02)00703-6 · Cited by 83
“Telomeres are maintained by a specialized reverse transcriptase, the ribonucleoprotein telomerase, which is composed of a ubiquitously expressed RNA subunit, Telomerase RNA Component (TERC) [12],”
BackgroundMarušić, L., Anton, M., Tidy, A., Wang, P., Villeponteau, B., & Bacchetti, S. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.11.6394 · Cited by 74
“In human cells, in particular, elongation of telomeres by introduction of oligonucleotides (59) or inhibition of telomerase by chromosome transfer (46), antisense strategies (21), or chemicals (53) has resulted in a prolonged life span or loss of cell viability, respectively.”
BackgroundResultInfluentialSelf-citationBechter, O. E., Eisterer, W., Dlaska, M., Kühr, T., & Thaler, J. (2002) · Experimental Hematology · doi:10.1016/s0301-472x(01)00760-3 · Cited by 87
“Its gene is consecutively expressed in both embryonic and adult human tissue [11,12].”
BackgroundThe Product of the Survival of Motor Neuron(SMN) Gene is a Human Telomerase-associated Protein
Bachand, F., Boisvert, F., Côté, J., Richard, S., & Autexier, C. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-04-0216 · Cited by 89
“The lack of a TMG cap at the 5 end of hTR is thus surprising, because it is expressed from its own promoter as an RNA polymerase II transcript (Feng et al., 1995; Hinkley et al., 1998).”
BackgroundGómez‐Millán, J., Goldblatt, E. M., Gryaznov, S. M., Mendonca, M. S., & Herbert, B. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.09.038 · Cited by 81
Shin, K.-H., Kang, M., Dicterow, E., & Park, N.-H. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601291 · Cited by 85
“…senescence; fibroblasts; keratinocytes Telomerase is complex, composed of a ribonucleoprotein, reverse transcriptase catalytic subunit, hTERT, template, hTR, and several associated protein cofactors (Feng et al, 1995; Harrington et al, 1997; Meyerson et al, 1997; Nakamura et al, 1997).”
BackgroundPotent inhibition of human telomerase by helenalin
Huang, P., Yeh, Y., & Wang, T. V. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.11.045 · Cited by 77
“Indeed, inhibition of telomerase has been shown to limit the growth of human cancer cells in culture [10–13], supporting the potential use of telomerase inhibition for cancer therapy.”
BackgroundSimilarities between long interspersed element-1 (LINE-1) reverse transcriptase and telomerase
Kopera, H. C., Moldovan, J. B., Morrish, T. A., Garcia-Perez, J. L., & Moran, J. V. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100275108 · Cited by 66
Donna, S. D., Mamchaoui, K., Cooper, R. N., Seigneurin-Venin, S., Tremblay, J. P., Butler-Browne, G. S., & Mouly, V. (2003) · PubMed · Cited by 89
Agents that target telomerase and telomeres
Raymond, É., Sun, D., Chen, S. F., Windle, B., & Hoff, D. D. V. (1996) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(96)80068-1 · Cited by 81
Villa, R., Daidone, M. G., Motta, R., Venturini, L., Marco, C. D., Vannelli, A., Kusamura, S., Baratti, D., Deraco, M., Costa, A., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0099 · Cited by 79
Duangmano, S., Dakeng, S., Jiratchariyakul, W., Suksamrarn, A., Smith, D. R., & Patmasiriwat, P. (2010) · International Journal of Molecular Sciences · doi:10.3390/ijms11125323 · Cited by 77
“Telomerase plays a role in cell proliferation as a protective mechanism against end-replication problems by adding TTAGGG repeats to the telomeres [11].”
BackgroundSignificance of Immunological Detection of Human Telomerase Reverse Transcriptase
Kyo, S., Masutomi, K., Maida, Y., Kanaya, T., Yatabe, N., Nakamura, M., Tanaka, M., Takarada, M., Sugawara, I., Murakami, S., et al. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63446-3 · Cited by 84
Analysis of telomerase activity and detection of its catalytic subunit, hTERT
Saldanha, S. N., Andrews, L. G., & Tollefsbol, T. O. (2003) · Analytical Biochemistry · doi:10.1016/s0003-2697(02)00663-2 · Cited by 79
2-5A Antisense Directed against Telomerase RNA Produces Apoptosis in Ovarian Cancer Cells
Kushner, D. M., Paranjape, J. M., Bandyopadhyay, B., Cramer, H., Leaman, D. W., KENNEDY, A. W., Silverman, R. H., & Cowell, J. K. (2000) · Gynecologic Oncology · doi:10.1006/gyno.1999.5668 · Cited by 82
Antiadhesive Effects of GRN163L—An Oligonucleotide N3′→P5′ Thio-Phosphoramidate Targeting Telomerase
Jackson, S. R., Zhu, C.-H., Paulson, V., Watkins, L., Dikmen, Z. G., Gryaznov, S. M., Wright, W. E., & Shay, J. W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2306 · Cited by 72
Dyrk2-associated EDD-DDB1-VprBP E3 Ligase Inhibits Telomerase by TERT Degradation
Jung, H., Wang, X., Jun, S., & Park, J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.416792 · Cited by 79
“Telomerase is composed of two subunits: telomerase RNA template (TERC),(2) an RNA template, and telomerase reverse transcriptase (TERT) (8).”
BackgroundTargeting telomerase for its advent in cancer therapeutics
Bajaj, S., Kumar, M. S., Peters, G. J., & Mayur, Y. (2020) · Medicinal Research Reviews · doi:10.1002/med.21674 · Cited by 78
Folini, M., Colella, G., Villa, R., Lualdi, S., Daidone, M. G., & Zaffaroni, N. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00870.x · Cited by 80
Unlimited Mileage from Telomerase?
de Lange, T., & DePinho, R. A. (1999) · Science · doi:10.1126/science.283.5404.947 · Cited by 71
The Discovery of Reverse Transcriptase
Coffin, J. M., & Fan, H. (2016) · Annual Review of Virology · doi:10.1146/annurev-virology-110615-035556 · Cited by 71
Khan, R. A., Khan, M. R., Sahreen, S., & Shah, N. A. (2012) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-12-90 · Cited by 71
“Figure 1 (a) Hemotoxylin and Eosin-stained liver section of control ra changes, cellular hypertrophy, degeneration of the lobular architectu Liver section of CCl4 + SAME showing less injuries (d) Liver section of Catalase, superoxide dismutase, and GSH-Px constitute a “mutually supportive team” of antioxidant defenses…”
Platycodin D induces apoptosis and decreases telomerase activity in human leukemia cells
Kim, M.-O., Moon, D., Choi, Y. H., Shin, D. Y., Kang, H. S., Choi, B. T., Lee, J.-D., Li, W., & Kim, G. (2008) · Cancer Letters · doi:10.1016/j.canlet.2007.11.010 · Cited by 74
“The telomerase complex is composed of a catalytic subunit, telomerase reverse transcriptase (hTERT) [3,4], telomerase RNA (TR) [5], telome-”
BackgroundChang, J. T., Lu, Y.-C., Chen, Y., Tseng, C.-P., Chen, Y.-L., Fang, C.-W., & Cheng, A.-J. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603008 · Cited by 71
“…is a holoenzyme consisting of several subunits including hTR (human telomerase RNA), TEP1 (telomeraseassociated protein1), hTERT (human telomerase reverse transcriptase), hsp90 (heat shock protein 90), p23, and dyskerin. hTR functions as a template for telomere elongation (Feng et al, 1995).”
Inhibitory effects of costunolide on the telomerase activity in human breast carcinoma cells
Choi, S.-H., Im, E., Kang, H., Lee, J.-H., Kwak, H.-S., Bae, Y., Park, H.-J., & Kim, N. D. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.01.011 · Cited by 73
In vivo regulation of telomerase activity and telomere length
Hathcock, K. S., Jeffrey Chiang, Y., & Hodes, R. J. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00267.x · Cited by 71
“of two essential components, a highly conserved catalytic reverse transcriptase (TERT) (5, 6) and a template RNA (TR) (7, 8).”
BackgroundTelomeres, telomerase, and cancer: life on the edge of genomic stability
Oulton, R., & Harrington, L. A. (2000) · Current Opinion in Oncology · doi:10.1097/00001622-200001000-00013 · Cited by 78
Telomerase Maintains Telomere Structure in Normal Human Cells
Masutomi, K., Yu, E. Y., Khurts, S., Ben-Porath, I., Currier, J. L., Metz, G. B., Brooks, M. W., Kaneko, S., Murakami, S., DeCaprio, J. A., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00550-6 · Cited by 70
RETRACTED: Two RNA subunits and POT1a are components of Arabidopsis telomerase
Cifuentes‐Rojas, C., Kannan, K. P., Tseng, L., & Shippen, D. E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013021107 · Cited by 70
“Unlike human (30) and yeast TER (31), we found no evidence of a poly-A tail for either Arabidopsis RNA.”
BackgroundRetractedTanaka, Y., Moritoh, Y., & Miwa, N. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21322 · Cited by 73
“…composed of both a catalytic core of a reverse transcriptase (hTERT) as a whole molecule and an RNA template component (hTR) [Greider and Blackburn, 1989; Feng et al., 1995; Lingner et al., 1997;Meyerson et al., 1997; Nakamura et al., 1997], and has a slight activity in normal human somatic cells.”
BackgroundTing, N. S. Y., Pohorelic, B. K. J., Yu, Y., Lees‐Miller, S. P., & Beattie, T. L. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp636 · Cited by 76
“Unlike hTERT and telomerase activity, which are only present in germ cells, stem cells and cells with a high proliferative index, hTR is ubiquitously expressed in somatic cells (52).”
BackgroundTelomerase activation: A potential key modulator for human healthspan and longevity
Boccardi, V., & Paolisso, G. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2013.12.006 · Cited by 71
Yokoi, S., Yasui, K., Iizasa, T., Imoto, I., Fujisawa, T., & Inazawa, J. (2003) · PubMed · Cited by 78
The significance of human telomerase reverse transcriptase (hTERT) in cancer
Kirkpatrick, K. L., & Mokbel, K. (2001) · European Journal of Surgical Oncology · doi:10.1053/ejso.2001.1151 · Cited by 79
Wang, L., Soria, J., Chang, Y. S., Lee, H., Wei, Q., & Mao, L. (2003) · Oncogene · doi:10.1038/sj.onc.1206852 · Cited by 74
“Telomerase is composed of an RNA component, a catalytic protein subunit, and other telomerase-associated proteins whose functions remain to be established (Feng et al., 1995).”
BackgroundWidschwendter, A., Müller, H. M., Hubalek, M., Wiedemair, A., Fiegl, H., GOEBEL, G., Mueller‐Holzner, E., Marth, C., & Widschwendter, M. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.01.036 · Cited by 81
“The enzyme telomerase is a ribonucleoprotein, comprising an RNA template (hTR) [12] and protein components, the telomerase-associated protein (TP1) [13] and the catalytic subunit (hTERT) [14–16].”
BackgroundStem-Loop IV of Tetrahymena Telomerase RNA Stimulates Processivity in trans
Mason, D. X., Goneska, E., & Greider, C. W. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.16.5606-5613.2003 · Cited by 81
“Telomerase RNA, first identified from the ciliate Tetrahymena thermophila (16), has been cloned from a number of different organisms, including other ciliates (22, 25, 26, 30, 31), Saccharomyces cerevisiae (27, 32), and vertebrates (8, 10, 14).”
BackgroundSelf-citationExpression of the RNA component of telomerase during human development and differentiation.
Yashima, K., Maitra, A., Rogers, B. B., Timmons, C. F., Rathi, A., Pınar, H., Wright, W. E., Shay, J. W., & Gazdar, A. F. (1998) · PubMed · Cited by 94
Does the reservoir for self-renewal stem from the ends?
Harrington, L. A. (2004) · Oncogene · doi:10.1038/sj.onc.1207948 · Cited by 77
“The mammalian homologues of these components were identified soon thereafter (Blasco et al., 1995; Feng et al., 1995; Harrington et al., 1997; Kilian et al., 1997; Meyerson et al., 1997; Nakamura et al., 1997).”
BackgroundSpecific telomerase RNA residues distant from the template are essential for telomerase function
Roy, J., Fulton, T. B., & Blackburn, E. H. (1998) · Genes & Development · doi:10.1101/gad.12.20.3286 · Cited by 70
“…200 nucleotides in ciliates (Greider and Blackburn 1989; Shippen-Lentz and Blackburn 1990) and ∼400 to 450 nucleotides in mammals (Blasco et al. 1995; Feng et al. 1995) to 1200–1300 nucleotides in the yeasts Saccharomyces cerevisiae and Kluyveromyces lactis (Singer and Gottschling 1994; McEachern…”
BackgroundPharmaceutical regulation of telomerase and its clinical potential
Sprouse, A. A., Steding, C. E., & Herbert, B. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01460.x · Cited by 70
“The telomerase RNA template (hTR or hTERC) contains a complementary sequence to the human telomere that serves as the base for replication of the telomere repeat sequence [20, 21].”
BackgroundDeng, W., Jayachandran, G., Wu, G., Xu, K., Roth, J. A., & Ji, L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610579200 · Cited by 72
Benvenuti, S., Saccardi, R., Luciani, P., Urbani, S., Deledda, C., Cellai, I., Francini, F., Squecco, R., Rosati, F., Danza, G., et al. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.04.016 · Cited by 69
“Conversely, low levels of expression are detected in quiescent or terminally differentiated cells [34].”
BackgroundResultKiaris, H., & Schally, A. V. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.226 · Cited by 70
Telomerase: a therapeutic target for the third millennium?
Lavelle, F., Riou, J., Laoui, A., & Mailliet, P. (2000) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(00)00057-3 · Cited by 74
Expression of Human Telomerase RNA Is an Early Event of Stomach Carcinogenesis
Kuniyasu, H., Domen, T., Hamamoto, T., Yokozaki, H., Yasui, W., Tahara, H., & Tahara, E. (1997) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1997.tb00353.x · Cited by 75
Telomeres, telomerase, and apoptosis
Mondello, C., & Scovassi, A. I. (2004) · Biochemistry and Cell Biology · doi:10.1139/o04-048 · Cited by 73
Telomeres and Cancer: Resolving the Paradox
Nassour, J., Schmidt, T. T., & Karlseder, J. (2021) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-050420-023410 · Cited by 74
“Since TERC, in contrast to TERT (Kim et al. 1994), is ubiquitously expressed in all human tissues (Feng et al. 1995) and since ectopic TERT expression is sufficient to immortalize human primary cells, there is likely no evolutionary pressure during tumorigenesis to select for activating TERC…”
BackgroundTham, C. Y., Poon, L.-F., Yan, T., Koh, J. Y. P., Ramlee, M. K., Teoh, V. S. I., Zhang, S., Cai, Y., Hong, Z., Lee, G. S., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-35823-7 · Cited by 89
Murakami, J., Nagai, N., Shigemasa, K., & Ohama, K. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00037-4 · Cited by 68
Liu, X., Wei, M., Liu, Y., Lv, B., Wei, W., Zhang, Y., & Liu, S. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.6b01817 · Cited by 69
Telomere restoration and extension of proliferative lifespan in dyskeratosis congenita fibroblasts
Westin, E. R., Chavez, E., Lee, K. M., Gourronc, F. A., Riley, S., Lansdorp, P. M., Goldman, F. D., & Klingelhutz, A. J. (2007) · Aging Cell · doi:10.1111/j.1474-9726.2007.00288.x · Cited by 69
Wang, S., & Zhu, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209544200 · Cited by 72
Self-citationhTERT Gene Amplification and Increased mRNA Expression in Central Nervous System Embryonal Tumors
Fan, X., Wang, Y., Kratz, J. E., Brat, D. J., Robitaille, Y., Moghrabi, A., Perlman, E. J., Dang, C. V., Burger, P. C., & Eberhart, C. G. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64311-8 · Cited by 76
Changes in Telomerase Activity and Telomere Length during Human T Lymphocyte Senescence
Pan, C.-X., Xue, B.-H., Ellis, T. M., Peace, D. J., & Díaz, M. O. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3475 · Cited by 71
Mccormick-Graham, M., & Romero, D. P. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1871 · Cited by 64
“Telomerase RNAs from mammalian cells (11, 17) and the yeasts S.”
BackgroundXu, X., Wei, M., Liu, Y., Liu, X., Wei, W., Zhang, Y., & Liu, S. (2016) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2016.09.005 · Cited by 67
The Shelterin TIN2 Subunit Mediates Recruitment of Telomerase to Telomeres
Frank, A. K., Tran, D. C., Qu, R. W., Stohr, B. A., Segal, D. J., & Xu, L. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005410 · Cited by 70
Telomerase in kinetoplastid parasitic protozoa
Cano, M. I. N., Dungan, J. M., Agabian, N. M., & Blackburn, E. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3616 · Cited by 78
Ohnishi, M., Yoshimi, N., Kawamori, T., Ino, N., Hirose, Y., Tanaka, T., Yamahara, J., Miyata, H., & Mori, H. (1997) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1997.tb00355.x · Cited by 67
hTERT promoter activity and CpG methylation in HPV-induced carcinogenesis
de Wilde, J., Kooter, J. M., Overmeer, R., Claassen-Kramer, D., Meijer, C. J. L. M., Snijders, P. J. F., & Steenbergen, R. D. M. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-271 · Cited by 72
Renaud, S., Loukinov, D. I., Alberti, L., Vostrov, A. A., Kwon, Y., Bosman, F. T., Lobanenkov, V. V., & Benhattar, J. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq827 · Cited by 70
hTERT promotes cell adhesion and migration independent of telomerase activity
Liu, H., Liu, Q., Ge, Y., Zhao, Q., Zheng, X., & Zhao, Y. B. (2016) · Scientific Reports · doi:10.1038/srep22886 · Cited by 76
Evaluation of intracellular telomerase activity through cascade DNA logic gates
Wang, W., Huang, S., Li, J., Rui, K., Bi, S., Zhang, J., & Zhu, J. (2016) · Chemical Science · doi:10.1039/c6sc01953f · Cited by 69
The Emerging Roles for Telomerase in the Central Nervous System
Liu, M., Nemes, A. D., & Zhou, Q. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00160 · Cited by 78
“TERC acts as a template for the addition of TTAGGG at the end of telomeric DNA in humans (Feng et al., 1995; Harrington et al., 1997).”
BackgroundSimon, M., Park, T., Leuenroth, S., Hans, V., Löning, T., & Schramm, J. (2000) · Journal of neurosurgery · doi:10.3171/jns.2000.92.5.0832 · Cited by 71
Lavranos, T. C., Mathis, J. M., Latham, S., Kalionis, B., Shay, J. W., & Rodgers, R. J. (1999) · Biology of Reproduction · doi:10.1095/biolreprod61.2.358 · Cited by 67
“The telomerase enzyme has two components—a protein catalytic component and an RNA component containing the complementary repeat sequence [3, 4].”
BackgroundHarley, C. B. (2007) · Novartis Foundation Symposia · doi:10.1002/9780470515433.ch9 · Cited by 67
Self-citationMartı́n-Rivera, L., & Blasco, M. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008419200 · Cited by 66
Evidence for a putative telomerase repressor gene in the 3p14.2–p21.1 region
Tanaka, H., Shimizu, M., Horikawa, I., Kugoh, H., Yokota, J., Barrett, J. C., & Oshimura, M. (1998) · Genes, Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199810)23:2<123::aid-gcc5>3.0.co;2-4 · Cited by 67
A novel mechanism for chaperone-mediated telomerase regulation during prostate cancer progression.
Akalin, A., Elmore, L. W., Forsythe, H. L., Amaker, B. A., McCollum, E. D., Nelson, P. S., Ware, J. L., & Holt, S. E. (2001) · PubMed · Cited by 90
Melek, M., Greene, E. C., & Shippen, D. E. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.7.3437 · Cited by 73
“A ribonucleoprotein, telomerase is an unusual reverse transcriptase that directs the synthesis of telomere repeat arrays by copying a sequence within its RNA subunit (4, 12, 18, 29, 31, 43, 44).”
BackgroundMarconett, C. N., Sundar, S. N., Tseng, M., Tin, A. S., Tran, K. Q., Mahuron, K. M., Bjeldanes, L. F., & Firestone, G. L. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr116 · Cited by 64
Alonso, M. M., Fueyo-Margareto, J., Shay, J. W., Aldape, K., Jiang, H., Lee, O.-H., Johnson, D. G., Xu, J., Kondo, Y., Kanzawa, T., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji340 · Cited by 66
de Kok, J. B., Ruers, T. J. M., van Muijen, G. N. P., van Bokhoven, A., Willems, H. L., & Swinkels, D. W. (2000) · Clinical Chemistry · doi:10.1093/clinchem/46.3.313 · Cited by 72
“Telomerase activity is the most general molecular marker for the identification of human cancer and can be detected in 85% of all tumors, whereas most healthy tissues exhibit little or no telomerase expression (11, 12 ). The enzyme needs at least two components to be functional: the RNA component, coded by the human t…”
BackgroundTelomerase: A Potential Diagnostic and Therapeutic Tool in Canine Oncology
Argyle, D. J., & Nasir, L. (2003) · Veterinary Pathology · doi:10.1354/vp.40-1-1 · Cited by 77
The role of telomeres and telomerase in the pathology of human cancer and aging
Shin, J., Hong, A., Solomon, M. J., & Lee, C. S. (2006) · Pathology · doi:10.1080/00313020600580468 · Cited by 81
Fibroblast growth factor 2 up regulates telomerase activity in neural precursor cells
Haïk, S., Gauthier, L., Granotier-Beckers, C., Peyrin, J., Lages, C. S., Dormont, D., & Boussin, F. D. (2000) · Oncogene · doi:10.1038/sj.onc.1203596 · Cited by 75
“…protein TERT (Meyerson et al., 1997; Nakamura et al., 1997; Nakayama et al., 1998) is a reverse transcriptase that uses an internal RNA molecule (termed mTER for the mouse) as template to add telomeric repeat sequences onto chromosome ends (Blasco et al., 1995; Feng et al., 1995; Greider, 1991).”
BackgroundWon, J., Yim, J., & Kim, T. K. (2002) · The FASEB Journal · doi:10.1096/fj.02-0311fje · Cited by 66
Metadata
- Authors
- Feng, J., Funk, W. D., Wang, S.-S., Weinrich, S. L., Avilion, A. A., Chiu, C.-P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., Le, S., West, M. D., Harley, C. B., Andrews, Greider, C. W., & Villeponteau, B.
- Affiliations
- Geron (United States) (US)
- Cold Spring Harbor Laboratory (US)
- ORCID
- Venue
- Science
- Published
- 1995-09
- Volume
- 269
- Issue
- 5228
- Pages
- 1236-1241
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2026856852
- Cited by
- 2,227
- References
- 44
- Citations by year
- 2026: 10 · 2025: 23 · 2024: 20 · 2023: 36 · 2022: 35 · 2021: 33 · 2020: 44 · 2019: 52 · 2018: 55 · 2017: 44 · 2016: 74 · 2015: 54 · 2014: 47 · 2013: 62 · 2012: 61
- FWCI
- 54.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG09383)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
- Keywords
- telomerase, hTR, telomeric repeats, antisense RNA, telomere shortening, HeLa cells
- MeSH terms
- Animals, Base Sequence, Cell Division, Cell Line, Cloning, Molecular, DNA Nucleotidylexotransferase, HeLa Cells, Humans, Molecular Sequence Data, RNA, Templates, Genetic, Transfection, Tumor Cells, Cultured, Polymerase Chain Reaction, Oligonucleotides, Antisense, Cell Death
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.